These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 31167847)

  • 1. Calibration and Evaluation of Quantitative Antibody Titers for Varicella-Zoster Virus by Use of the BioPlex 2200.
    McLachlan E; Scholz H; Bolotin S; Crowcroft NS; Hatchette TF; Jackson C; Severini A;
    J Clin Microbiol; 2019 Aug; 57(8):. PubMed ID: 31167847
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of the Bio-Rad BioPlex Measles, Mumps, Rubella, and Varicella-Zoster Virus IgG multiplex bead immunoassay.
    Binnicker MJ; Jespersen DJ; Rollins LO
    Clin Vaccine Immunol; 2011 Sep; 18(9):1524-6. PubMed ID: 21795463
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Performance Characteristics of a Multiplex Flow Immunoassay for Detection of IgG-Class Antibodies to Measles, Mumps, Rubella, and Varicella-Zoster Viruses in Presumptively Immune Health Care Workers.
    Theel ES; Sorenson M; Rahman C; Granger D; Vaughn A; Breeher L
    J Clin Microbiol; 2020 Mar; 58(4):. PubMed ID: 32024728
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Calibration and Evaluation of Quantitative Antibody Titers for Measles Virus by Using the BioPlex 2200.
    Hatchette TF; Scholz H; Bolotin S; Crowcroft NS; Jackson C; McLachlan E; Severini A
    Clin Vaccine Immunol; 2017 Jan; 24(1):. PubMed ID: 27852634
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of a bead-based multiplex immunoassay for simultaneous quantitative detection of IgG serum antibodies against measles, mumps, rubella, and varicella-zoster virus.
    Smits GP; van Gageldonk PG; Schouls LM; van der Klis FR; Berbers GA
    Clin Vaccine Immunol; 2012 Mar; 19(3):396-400. PubMed ID: 22237896
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of IgG-class antibodies to measles, mumps, rubella, and varicella-zoster virus using a multiplex bead immunoassay.
    Dhiman N; Jespersen DJ; Rollins LO; Harring JA; Beito EM; Binnicker MJ
    Diagn Microbiol Infect Dis; 2010 Aug; 67(4):346-9. PubMed ID: 20638602
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of the Vidas and Bio-Whittaker enzyme immunoassays for detecting IgG reactive with varicella-zoster virus and mumps virus.
    Doern GV; Robbie L; St Amand R
    Diagn Microbiol Infect Dis; 1997 May; 28(1):31-4. PubMed ID: 9218916
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Performance characteristics of a quantitative, standardised varicella zoster IgG time resolved fluorescence immunoassay (VZV TRFIA) for measuring antibody following natural infection.
    Chris Maple PA; Gray J; Brown K; Brown D
    J Virol Methods; 2009 Apr; 157(1):90-2. PubMed ID: 19135089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Field Test and Validation of the Multiplier Measles, Mumps, Rubella, and Varicella-Zoster Multiplexed Assay System in the Democratic Republic of the Congo by Using Dried Blood Spots.
    Higgins SG; Hoff NA; Gadoth A; Fusellier A; Mukadi P; Alfonso V; Randall C; Ashbaugh H; Poncheri M; Doshi RH; Gerber S; Budd R; Wolfert R; Williams R; Okitolonda-Wemakoy E; Muyembe-Tamfum JJ; Rimoin AW
    mSphere; 2019 Aug; 4(4):. PubMed ID: 31413172
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of intrathecal IgG antibody for varicella and measles diagnosis by evaluation and comparison of a commercial IgG chemiluminescent immunoassay with two ELISAs.
    Garcia R; Jiménez-Valera M; Ruiz-Buck D; Sanchez C; Rojas A; Schütz MH; Rojas J; Hunfeld KP
    Eur J Clin Microbiol Infect Dis; 2024 Jun; 43(6):1139-1148. PubMed ID: 38613705
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Serological detection of varicella-zoster virus-specific immunoglobulin G by an enzyme-linked immunosorbent assay using glycoprotein antigen.
    Sauerbrei A; Wutzler P
    J Clin Microbiol; 2006 Sep; 44(9):3094-7. PubMed ID: 16954232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Poor recall of prior exposure to varicella zoster, rubella, measles, or mumps in patients with IBD.
    Naganuma M; Nagahori M; Fujii T; Morio J; Saito E; Watanabe M
    Inflamm Bowel Dis; 2013 Feb; 19(2):418-22. PubMed ID: 22605673
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Study of the antibodies against measles, rubella, mumps and varicella-zoster viruses in sera from the medical staffs].
    Shiraishi T; Nakagawa M; Nakagawa Y; Tominaga M; Yoshitani S
    Kansenshogaku Zasshi; 2005 May; 79(5):322-8. PubMed ID: 15977572
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Antibody titers against measles, rubella, mumps and varicella-zoster viruses in medical students].
    Yoshida N; Tsumura N; Toyomasu K; Sagawa K
    Sangyo Eiseigaku Zasshi; 2007 Jan; 49(1):21-6. PubMed ID: 17303935
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Seroprevalence of measles, mumps, rubella, and varicella zoster virus antibodies among healthcare students: analysis of vaccine efficacy and cost-effectiveness.
    Ödemiş Í; Köse Ş; Akbulut Í; Albayrak H
    Rev Esp Quimioter; 2019 Dec; 32(6):525-531. PubMed ID: 31642641
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Serologic analysis of the IgG antibody response in children with varicella zoster virus wild-type infection and vaccination.
    Jenke AC; Klein S; Baiker A; Wirth S; Sander M; Noelting C; Boecher O; Vizoso-Pinto MG
    Pediatr Infect Dis J; 2012 Nov; 31(11):1148-52. PubMed ID: 22863912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The differences in short- and long-term varicella-zoster virus (VZV) immunoglobulin G levels following varicella vaccination of healthcare workers measured by VZV fluorescent-antibody-to-membrane-antigen assay (FAMA), VZV time-resolved fluorescence immunoassay and a VZV purified glycoprotein enzyme immunoassay.
    Maple PA; Haedicke J; Quinlivan M; Steinberg SP; Gershon AA; Brown KE; Breuer J
    Epidemiol Infect; 2016 Aug; 144(11):2345-53. PubMed ID: 27018820
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Performance of a time-resolved fluorescence immunoassay for measuring varicella-zoster virus immunoglobulin G levels in adults and comparison with commercial enzyme immunoassays and Merck glycoprotein enzyme immunoassay.
    Maple PA; Gray J; Breuer J; Kafatos G; Parker S; Brown D
    Clin Vaccine Immunol; 2006 Feb; 13(2):214-8. PubMed ID: 16467328
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seroprevalence of antibodies against varicella zoster virus and rubella virus among newly recruited expatriate healthcare workers: a cross-sectional study.
    Shady I
    BMJ Open; 2018 Mar; 8(3):e019339. PubMed ID: 29567844
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Evaluation of three commercial varicella-zoster virus IgG enzyme-linked immunosorbent assays in comparison to the fluorescent-antibody-to-membrane-antigen test.
    Sauerbrei A; Schäfler A; Hofmann J; Schacke M; Gruhn B; Wutzler P
    Clin Vaccine Immunol; 2012 Aug; 19(8):1261-8. PubMed ID: 22718131
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.